Datong Tang

This inventor holds 30 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent, primarily in Hepatitis C Inhibitors. Top assignee: Enanta Pharmaceuticals, Inc.. Active years: 2007-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Datong Tang. Retrieved from https://idiyas.com/inventor/datong-tang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30

% Patents Active = 50.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 4)

Average Co-Inventor Count = 6.1

ph-index = 7

Forward Citations = 235(Granted Patents)

Location History:

Brighton, MA (US) (2009)
Malden, MA (US) (2007 - 2010)
Watertown, MA (US) (2007 - 2011)
Newton, MA (US) (2009 - 2016)

Company Filing History:

30 out of 299

Enanta Pharmaceuticals, Inc.

patents

Years Active: 2007-2016

Loading Chart...

Areas of Expertise:

Hepatitis C

Quinoxalinyl Derivatives

Bicyclic Erythromycin

Macrocyclic Inhibitors

Serine Protease

Antivirals

Tri-Peptide

Hydroxylamines

Bicyclolides

Carboxylic Acid

Inhibitors

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9242974 - Processes for the preparation of 2-fluoro 6-11 bicyclic erythromycin derivatives (2016-01-26),

2. 8962551 - Quinoxalinyl derivatives (2015-02-24),

3. 8927739 - Processes for the preparation of 5-azaspiro[2.4]heptane-6-carboxylic acid and its derivatives (2015-01-06),

4. 8921573 - Processes for the preparation of novel benzimidazole derivatives (2014-12-30),

5. 8809264 - Quinoxalinyl macrocyclic hepatitis C virus serine protease inhibitors (2014-08-19),

6. 8778938 - Hepatitis C virus inhibitors (2014-07-15),

7. 8609648 - Hepatitis C virus inhibitors (2013-12-17),

8. 8552162 - Processes for the preparation of 2 fluoro 6-11 bicyclic erythromycin derivatives (2013-10-08),

9. 8501681 - Macrocyclic hepatitis C virus serine protease inhibitors (2013-08-06),

10. 8426458 - Hepatitis C Virus inhibitors (2013-04-23),

11. 8420686 - Linked diimidazole antivirals (2013-04-16),

12. 8236807 - Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors (2012-08-07),

13. 8124584 - Macrocyclic hepatitis C serine protease inhibitors (2012-02-28),

14. RE42375 - Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors (2011-05-16),

15. 7919627 - Processes for the preparation of hydroxylamines (2011-04-05),

Title: Inventor Datong Tang: Revolutionizing Technology in Newton, MA

Introduction: Datong Tang is a visionary inventor based in Newton, MA, known for his groundbreaking contributions to the field of technology.

Latest Patents: Datong Tang holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and innovation.

Career Highlights: With a career spanning over two decades, Datong Tang has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have had a significant impact on various industries.

Collaborations: Throughout his career, Datong Tang has collaborated with top scientists, engineers, and researchers globally, fostering a culture of innovation and knowledge sharing in the technology sector.

Conclusion: Datong Tang's relentless pursuit of innovation and his passion for pushing the boundaries of technology continue to inspire the next generation of inventors and entrepreneurs worldwide.

Profile summary based on public USPTO records.